Compare SYSCO Corporation (SYY) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SYSCO Corporation vs Tenet Healthcare Corporation — how do they compare? SYSCO Corporation trades at $78.14 (market cap $38.47B), while Tenet Healthcare Corporation trades at $263.78 (market cap $20.98B). The key difference: SYSCO Corporation is the larger of the two by market cap, and SYSCO Corporation pays a 2.81% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold SYSCO Corporation for 77 Days and Tenet Healthcare Corporation for 15 Days on average.
| SYY | THC | |
|---|---|---|
Market Cap | $38.47B | $20.98B |
Volume | 4,808,465 | 428,008 |
Sector | Consumer Staples | Health |
52-Week High | $91.16 | $280.77 |
52-Week Low | $69.30 | $161.37 |
Typical Hold Time | 77 Days | 15 Days |
Enterprise Value | $51.65B | $32.06B |
Dividend Yield | 2.81% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sysco (SYY) trades at $78.20, up 1.84% with neutral technical signals. The company shows steady revenue growth to $81.37B in 2025, though net margins remain thin at 2.08%. Recent corporate actions include a $1.5B senior notes offering and a $500M AI efficiency program targeting cost savings. Analyst consensus is bullish with 60% buy ratings and an $85.75 price target, representing 9.6% upside potential from current levels.
Sysco presents a balanced investment case with strong institutional support and dividend stability, but faces margin pressure and high debt levels. The AI efficiency initiative and consistent revenue growth provide catalysts, while competitive pressures and economic sensitivity pose risks. Current valuation appears reasonable with P/E of 21.37 and P/S of 0.44.
Tenet Healthcare (THC) trades at $260.57, showing modest daily gains of 0.28% with strong technical support at $257 and resistance at $262. The stock demonstrates robust fundamentals with a P/E of 10.07, net income margin of 9.9%, and consistent earnings beats in recent quarters. Recent news highlights the upcoming Q3 2026 earnings release on October 29, 2026, while the company maintains strong cash flow generation of $3.54 billion from operations.
THC presents a compelling investment case with 81% analyst buy ratings and a $283.36 consensus price target representing 8.7% upside potential. The company's expanding capital return strategy and projected revenue growth to $22.6 billion in 2026 support bullish sentiment, though investors should monitor surgical volume trends and capital allocation sustainability as key risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SYSCO Corporation
Sysco is the largest U.S. food-service distributor, boasting 17% market share of the highly fragmented food-service distribution industry. Sysco distributes over 400,000 food and nonfood products to restaurants (63% of revenue), healthcare facilities (8%), education and government buildings (8%), travel and leisure (7%), and other locations (14%) where individuals consume away-from-home meals. In fiscal 2022, 82% of the firm's revenue was U.S.-based, with 7% from Canada, 4% from the U.K., 2% from France, and 4% other.
Read more on SYY →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
